2
Clinical Trials associated with HRG2101HRG2101吸入剂在健康成人中单、多次给药的安全性、耐受性及药代动力学研究
[Translation] Safety, tolerability and pharmacokinetics of single and multiple doses of HRG2101 inhalation in healthy adults
考察健康受试者经口吸入HRG2101后的安全性、耐受性及药代动力学特征;考察吸入流速对HRG2101的生物利用度的影响;考察健康受试者经口吸入HRG2101后的胃肠道和肺部吸收比例;考察健康受试者多次经口吸入HRG2101后的体内蓄积情况;比较HRG2101吸入剂与吡非尼酮片的相对生物利用度。
[Translation] To investigate the safety, tolerability and pharmacokinetic characteristics of HRG2101 after oral inhalation in healthy subjects; to investigate the effect of inhalation flow rate on the bioavailability of HRG2101; to investigate the gastrointestinal and pulmonary absorption ratios after oral inhalation of HRG2101 in healthy subjects; to investigate the in vivo accumulation of HRG2101 after multiple oral inhalations in healthy subjects; and to compare the relative bioavailability of HRG2101 inhaler and pirfenidone tablets.
Safety, tolerability and pharmacokinetics of HRG2101 inhaler in single and multiple doses in healthy adults
Start Date21 Oct 2022 |
Sponsor / Collaborator- |
100 Clinical Results associated with HRG2101
100 Translational Medicine associated with HRG2101
100 Patents (Medical) associated with HRG2101
100 Deals associated with HRG2101